Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Amgen
Institute of Hematology & Blood Diseases Hospital, China
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Washington
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Children's Hospital of Philadelphia
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Comenius University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Nice
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Florida
Princess Maxima Center for Pediatric Oncology
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Janssen Research & Development, LLC
Murdoch Childrens Research Institute
University of Miami
Children's Oncology Group
PedAL BCU, LLC
TScan Therapeutics, Inc.
University of Rochester
Dana-Farber Cancer Institute
St. Justine's Hospital
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Northside Hospital, Inc.
University of Arizona
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
AstraZeneca
Novartis